Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
HitIQ Limited ( (AU:HIQ) ) has shared an update.
HITIQ Limited has announced the establishment of a new loan facility agreement, providing early access to R&D expenditure for the 2025 financial year. The facility, amounting to $800,000, is structured with terms consistent with previous agreements, including a 15% interest rate and a maturity date 365 days from the agreement. This development is anticipated to bolster HITIQ’s operational capacity, potentially enhancing its industry standing by leveraging the funding for further innovation and market competitiveness.
More about HitIQ Limited
HITIQ Limited is a company specializing in brain care solutions through advanced technology. Their products include sensor-enabled mouthguards and AI-driven data analytics interfaces, aiding in concussion management and brain impact studies. Their clientele spans major sports leagues like the AFL, EPL, and NRL, as well as universities and research institutions focused on head impact studies.
YTD Price Performance: -12.00%
Average Trading Volume: 262,557
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$16.21M
For a thorough assessment of HIQ stock, go to TipRanks’ Stock Analysis page.
